Scientific Research

The Scientific Research team at Kestrel Therapeutics focuses on discovering and developing novel molecules to target intractable cancers, particularly through potent inhibitors of pan-oncogenic-RAS. This team leverages advanced biological, biophysical, and structural biology methods to drive innovative cancer therapies, keeping patient outcomes at the forefront of their research efforts.